2509 — Qyuns Therapeutics Co Share Price
0.000.00%
Last trade - 00:00- HK$2.49bn
- HK$2.45bn
- CNY158.79m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.98 | ||
| Price to Tang. Book | 10.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 14.4 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -58.94% | ||
| Return on Equity | -128.15% | ||
| Operating Margin | -205.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | n/a | n/a | 158.79 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Qyuns Therapeutics Co Ltd is a China-based company mainly engaged in biopharmaceuticals. The Company is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The Company's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The Company is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The Company's core products include QX002N and QX005N.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 16th, 2015
- Public Since
- March 20th, 2024
- No. of Employees
- 339
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 222,071,600
- Address
- Room 1310, TAIZHOU
- Web
- https://www.qyuns.net/
- Phone
- +86 52380276311
- Auditors
- KPMG
Upcoming Events for 2509
Similar to 2509
Abbisko Cayman
Stock Exchange of Hong Kong Limited
Akeso
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
FAQ
What is the Qyuns Therapeutics Co share price?
As of Today at 22:49 UTC, shares in Qyuns Therapeutics Co are trading at HK$10.96. This share price information is delayed by 15 minutes.
How has the Qyuns Therapeutics Co share price performed this year?
Shares in Qyuns Therapeutics Co last closed at HK$10.96 and the price had moved by -56.16% over the past 365 days. In terms of relative price strength the Qyuns Therapeutics Co share price has underperformed the FTSE Developed Asia Pacific Index by -55.66% over the past year.
What are the analyst and broker recommendations for Qyuns Therapeutics Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Qyuns Therapeutics Co dividend yield?
Qyuns Therapeutics Co does not currently pay a dividend.
Does Qyuns Therapeutics Co pay a dividend?
Qyuns Therapeutics Co does not currently pay a dividend.
When does Qyuns Therapeutics Co next pay dividends?
Qyuns Therapeutics Co does not currently pay a dividend.
How do I buy Qyuns Therapeutics Co shares?
To buy shares in Qyuns Therapeutics Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Qyuns Therapeutics Co?
As of the previous close price of HK$10.96, shares in Qyuns Therapeutics Co had a market capitalisation of HK$2.49bn.
Where are Qyuns Therapeutics Co shares listed?
Here are the trading details for Qyuns Therapeutics Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2509
What kind of share is Qyuns Therapeutics Co?
Based on an overall assessment of its quality, value and momentum Qyuns Therapeutics Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Qyuns Therapeutics Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Qyuns Therapeutics Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Qyuns Therapeutics Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -15.6%.
As of the last closing price of HK$10.96, shares in Qyuns Therapeutics Co were trading -22.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Qyuns Therapeutics Co PE Ratio?
The Qyuns Therapeutics Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$10.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Qyuns Therapeutics Co?
We do not have data on Qyuns Therapeutics Co's directors